Cargando…

Predicting the effect of 5‐fluorouracil–based adjuvant chemotherapy on colorectal cancer recurrence: A model using gene expression profiles

It is critical to identify patients with stage II and III colorectal cancer (CRC) who will benefit from adjuvant chemotherapy (ACT) after curative surgery, while the only use of clinical factors is insufficient to predict this beneficial effect. In this study, we performed genetic algorithm (GA) to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Quan, Gao, Peng, Song, Yongxi, Huang, Xuanzhang, Xiao, Qiong, Chen, Xiaowan, Lv, Xinger, Wang, Zhenning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196071/ https://www.ncbi.nlm.nih.gov/pubmed/32150672 http://dx.doi.org/10.1002/cam4.2952

Ejemplares similares

The platelet to lymphocyte ratio is a potential inflammatory marker predicting the effects of adjuvant chemotherapy in patients with stage II colorectal cancer
por: Fu, Yu, et al.
Publicado: (2021)

tRFTars: predicting the targets of tRNA-derived fragments
por: Xiao, Qiong, et al.
Publicado: (2021)

Relationship between circulating tumor cells and tumor response in colorectal cancer patients treated with chemotherapy: a meta-analysis
por: Huang, Xuanzhang, et al.
Publicado: (2014)

A nomogram for predicting bowel obstruction in preoperative colorectal cancer patients with clinical characteristics
por: Lv, Xinger, et al.
Publicado: (2019)

Meta-analysis of the prognostic value of circulating tumor cells detected with the CellSearch System in colorectal cancer
por: Huang, Xuanzhang, et al.
Publicado: (2015)

The differences on efficacy of oxaliplatin in locally advanced colon cancer between mucinous and nonmucinous adenocarcinoma
por: Yu, Dehao, et al.
Publicado: (2018)

Do Patients with Second Primary Colorectal Cancer Hold the Similar Prognosis and Therapeutic Benefits as Those with Initial Primary Colorectal Cancer?
por: Chen, Quan, et al.
Publicado: (2018)

Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-Analysis
por: Sun, Jingxu, et al.
Publicado: (2016)

Prognostic significance of preoperative prognostic nutritional index in colorectal cancer: results from a retrospective cohort study and a meta-analysis
por: Yang, Yuchong, et al.
Publicado: (2016)

Predictive impact of the inflammation‐based indices in colorectal cancer patients with adjuvant chemotherapy
por: Tao, Yong, et al.
Publicado: (2018)

The efficacy of adding targeted agents to neoadjuvant therapy for locally advanced rectal cancer patients: a meta‐analysis
por: Zhong, Xi, et al.
Publicado: (2018)

Efficacy and safety of taxane-based systemic chemotherapy of advanced gastric cancer: A systematic review and meta-analysis
por: Shi, Jinxin, et al.
Publicado: (2017)

Long‐term symptoms of polyneuropathy in breast and colorectal cancer patients treated with and without adjuvant chemotherapy
por: Bennedsgaard, Kristine, et al.
Publicado: (2020)

Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials
por: Sun, Jingxu, et al.
Publicado: (2012)

Oral fluorouracil vs vinorelbine plus cisplatin as adjuvant chemotherapy for stage II‐IIIA non‐small cell lung cancer: Propensity score‐matched and instrumental variable analyses
por: Urushiyama, Hirokazu, et al.
Publicado: (2018)

The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer
por: Song, Yongxi, et al.
Publicado: (2017)

Prognostic evaluation of platelet to lymphocyte ratio in patients with colorectal cancer
por: Lu, Chong, et al.
Publicado: (2017)

Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study
por: De Placido, S, et al.
Publicado: (2005)

Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy
por: Hsieh, Mao‐Chih, et al.
Publicado: (2018)

Impact of adjuvant chemotherapy on outcomes in appendiceal cancer
por: Kolla, Bhaskar C., et al.
Publicado: (2020)

Docetaxel, Cisplatin, and 5‐Fluorouracil as perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma
por: Fiteni, Frédéric, et al.
Publicado: (2016)

Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer
por: Gusella, M, et al.
Publicado: (2009)

Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer
por: Karim, Safiya, et al.
Publicado: (2019)

Delayed initiation of adjuvant chemotherapy in older women with breast cancer
por: Smith‐Graziani, Demetria, et al.
Publicado: (2020)

The potential adjunctive benefit of adding metformin to standard treatment in inoperable cancer patients: a meta-analysis of randomized controlled trials
por: Wu, Zhonghua, et al.
Publicado: (2020)

Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy
por: Bhave, Prachi, et al.
Publicado: (2023)

Impact of adjuvant chemotherapy on the survival of patients with breast cancer diagnosed by screening
por: Zarcos‐Pedrinaci, Irene, et al.
Publicado: (2019)

Topoisomerase I and IIα protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy
por: Tsavaris, Nicolas, et al.
Publicado: (2008)

Topoisomerase I and IIα protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy
por: Tsavaris, Nicolas, et al.
Publicado: (2009)

Impact of age on adjuvant chemotherapy after radical resection in patients with non–small cell lung cancer
por: Zhai, Xiaoyu, et al.
Publicado: (2016)

Immunohistochemistry‐Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer
por: Li, Yaqi, et al.
Publicado: (2020)

Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs
por: Hao, Zhonglin, et al.
Publicado: (2022)

Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?
por: Melchior, Nicole M., et al.
Publicado: (2020)

Adjuvant chemotherapy versus chemoradiation in high‐risk pancreatic adenocarcinoma: A propensity score‐matched analysis
por: Raoof, Mustafa, et al.
Publicado: (2019)

Clinicopathologic characteristics and prognosis of Borrmann type IV gastric cancer: a meta-analysis
por: Luo, Yifan, et al.
Publicado: (2016)

Conversion Surgery for Stage IV Gastric Cancer
por: Zhang, Fei, et al.
Publicado: (2019)

GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy
por: Wang, Zaozao, et al.
Publicado: (2014)

The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients
por: Hsieh, Mei‐Chin, et al.
Publicado: (2016)

Consumption of Lactose, Other FODMAPs and Diarrhoea during Adjuvant 5-Fluorouracil Chemotherapy for Colorectal Cancer
por: Holma, Reetta, et al.
Publicado: (2020)

Clinical significance of promoter region hypermethylation of microRNA-148a in gastrointestinal cancers
por: Sun, Jingxu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0f75php7nff8bdhv0futv6hih0